Latest news
FDA panel’s peptide vote raises alarms among Phoenix-area health experts - AZ FamilyAZ Family · Fri, 07 Aug 2026 03:43:00 GMTFDA panel backs 6 peptides despite its own scientists’ objections - MassLiveMassLive · Mon, 03 Aug 2026 16:52:00 GMTFDA Advisory Panel Backs Replimune's Melanoma Drug - MedscapeMedscape · Fri, 31 Jul 2026 15:17:18 GMTFDA panel backs unapproved peptides despite safety concerns - Drug Discovery NewsDrug Discovery News · Fri, 31 Jul 2026 13:15:25 GMTFDA advisory committee backs RP1 efficacy in anti-PD-1–refractory advanced melanoma - AllSciAllSci · Fri, 31 Jul 2026 12:34:55 GMTReplimune Shares Take Flight Premarket After FDA Panel Backs RP1 - MoomooMoomoo · Fri, 31 Jul 2026 10:19:00 GMTFDA Panel Backs 6 Peptides for Compounding - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 31 Jul 2026 07:00:00 GMTFDA advisory panel backs Replimune’s nivolumab - The Pharma LetterThe Pharma Letter · Fri, 31 Jul 2026 07:00:00 GMT